These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


403 related items for PubMed ID: 15938735

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vitro properties of platelets stored in three different additive solutions.
    Tynngård N, Trinks M, Berlin G.
    Transfusion; 2012 May; 52(5):1003-9. PubMed ID: 22043825
    [Abstract] [Full Text] [Related]

  • 24. Platelet function in variable platelet split products intended for neonatal transfusion.
    Strasser EF, Stachel DK, Schwarzkopf P, Ringwald J, Weisbach V, Zimmermann R, Zingsem J, Eckstein R.
    Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A, Kurtz J, Moroff G, Wagner SJ.
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels.
    Wagner SJ, Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G.
    Transfusion; 2010 May; 50(5):1028-35. PubMed ID: 20030790
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
    Heddle NM, Barty RL, Sigouin CS, Boye DM, Nelson EJ, Blajchman MA, Kelton JG.
    Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
    [Abstract] [Full Text] [Related]

  • 31. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
    Tynngård N, Lindahl TL, Trinks M, Studer M, Berlin G.
    Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.
    Skripchenko A, Turgeon A, Thompson-Montgomery D, Awatefe H, Wagner SJ.
    Vox Sang; 2014 May; 106(4):337-43. PubMed ID: 24330192
    [Abstract] [Full Text] [Related]

  • 33. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma or 65% platelet additive solution III/35% plasma and including periods without agitation under simulated shipping conditions.
    Moroff G, Kurtz J, Seetharaman S, Skripchenko A, Awatefe H, Thompson-Montgomery D, Myrup A, Wagner SJ.
    Transfusion; 2012 Apr; 52(4):834-43. PubMed ID: 22014086
    [Abstract] [Full Text] [Related]

  • 34. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution.
    Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T, Nelson E.
    Transfusion; 2006 May; 46(5):835-40. PubMed ID: 16686852
    [Abstract] [Full Text] [Related]

  • 35. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia.
    Wang X, Fan Y, Shi R, Li J, Zhao S.
    Platelets; 2015 May; 26(1):72-9. PubMed ID: 24499059
    [Abstract] [Full Text] [Related]

  • 36. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG, Carter CJ, Culibrk B, Devine DV, Levin E, Scammell K, Weiss S, Gyongyossy-Issa MI.
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [Abstract] [Full Text] [Related]

  • 37. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma.
    Vassallo RR, Adamson JW, Gottschall JL, Snyder EL, Lee W, Houghton J, Elfath MD.
    Transfusion; 2010 Nov; 50(11):2376-85. PubMed ID: 20497516
    [Abstract] [Full Text] [Related]

  • 38. Cold storage of platelets in platelet additive solution: an in vitro comparison of two Food and Drug Administration-approved collection and storage systems.
    Reddoch-Cardenas KM, Montgomery RK, Lafleur CB, Peltier GC, Bynum JA, Cap AP.
    Transfusion; 2018 Jul; 58(7):1682-1688. PubMed ID: 29603238
    [Abstract] [Full Text] [Related]

  • 39. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
    de Wildt-Eggen J, Schrijver JG, Smid WM, Joie M, Bollinne V, Bins M.
    Vox Sang; 1998 Jul; 75(3):218-23. PubMed ID: 9852410
    [Abstract] [Full Text] [Related]

  • 40. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
    Sandgren P, Callaert M, Shanwell A, Gulliksson H.
    Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.